摘要
目的:评价茶碱缓释片联用孟鲁司特治疗咳嗽变异性哮喘的临床疗效。方法:将42例咳嗽变异性哮喘患者随机分为两组,治疗组应用茶碱缓释片0.2,每日2次;孟鲁司特咀嚼片10mg,每晚口服。对照组应用氨茶碱0.2,每日3次;酮替芬1mg,每日2次。3天及7天后比较疗效。结果:治疗组21例总有效率为95%,对照组为90%,两组总有效率比较差异有统计学意义(P<0.05)。结论:茶碱缓释片联用孟鲁司特治疗咳嗽变异性哮喘疗效肯定。
Objective ： Evaluation of theophyl- line combined with montelukast in the treat- ment of cough variant asthma therapy. Meth- ods：42 patients with cough variant asthma were randomly divided into two groups： treatment group theophylline 0.2 Bid, Mon- telukast Chewable Tablets 10mg Qn oral. Control group aminophylline 0.2 Tid, ketotifen l mg Bid. Compare effect after 3 days and 7 days . Results：The total effective rate of 21 patients with 95% efficiency of the control group was 90%, the total effective rate between the groups significantly （P 〈 0. 05 ）. Conclusion： Theophylline Sustained Release Tablets Montelukast can be used to treat of cough variant asthma sure.
